id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-3517-0017,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry",Other,Guidance,2016-06-10T04:00:00Z,2016,6,2016-06-10T04:00:00Z,,2025-01-07T21:45:03Z,,0,0,090000648202e5c4
FDA-2015-D-3517-0016,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability",Notice,Correction,2016-06-10T04:00:00Z,2016,6,2016-06-10T04:00:00Z,,2016-06-16T17:48:35Z,2016-13799,0,0,090000648202c0de